Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 141 Breast Neoplasms 10 Neoplasm Metastasis 8 Neoplasms 5 Bulbo-Spinal Atrophy, X-Linked 5 Triple Negative Breast Neoplasms 4 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 2 Osteoporosis 2 Lower Urinary Tract Symptoms 2 Hirsutism 2 Thrombocytosis 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Stage I Prostate Adenocarcinoma 1 Sexual Dysfunction, Physiological 1 Recurrence 1 Primary Myelofibrosis 1 Primary Dysautonomias 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Castrate Metastatic Prostate Cancer 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Gemcitabine 30 Mitomycin 25 BCG Vaccine 13 Docetaxel 10 Epirubicin 6 erdafitinib 5 durvalumab 5 dodecyl maltoside 5 Radiotherapy 5 Cystoscopy 5 apaziquone 4 ALT-803 4 tislelizumab 3 5-aminolevulinic acid hexyl ester 3 viscum album peptide 2 pembrolizumab 2 disitamab vedotin 2 avelumab 2 VB4-845 2 Therapeutics 2 Imiquimod 2 Hyaluronic Acid 2 Administration, Intravesical 2 1-phenyl-3,3-dimethyltriazene 2 vocimagene amiretrorepvec 1 valrubicin 1 tremelimumab 1 toripalimab 1 pirarubicin 1 pemigatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × bicalutamide × Clear all

NCT05327647 2025-12-18

BicaBCa

CHU de Quebec-Universite Laval

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡